Adverse patient events are more likely to be averted when trends are detected early. This is true for patients in a variety of clinical situations where the ventilation and oxygenation is affected.
Transcutaneous monitoring is a valuable tool, specifically in situations that generally preclude CO2 monitoring such as non-invasive ventilation, oxygen titration and permissive hypercapnia to assess the respiratory status of a patient.
Did you know that non-invasive monitoring of tcpCO2
- delivers continuous information on patients with respiratory shunt or V/Q mismatch
- detects hypercapnia in patients on supplemental oxygen
- supports a change in ventilator settings and weaning from ventilator
Monitoring of oxygen saturation (SpO2) is a standard of care in various clinical situations and combined with transcutaneous tcpCO2 it provides a complete picture of the ventilation and oxygenation status of a patient.
tcpCO2 monitoring of hypercapnic patients during therapy allows for early detection of changes in ventilatory status and prevents CO2 retention.